Investor Relations
The Leader in Brachytherapy
Isoray advances innovative radiotherapeutic technologies that focus on the patient.
Latest Results
Isoray Announces Second Quarter Fiscal 2021 Financial Results
Revenue Increased 7% Year-Over-Year Non-Prostate Brachytherapy Revenue Increased 92% Year-Over-Year RICHLAND, WASHINGTON – February 9, 2021 – Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding...
Isoray Announces First Quarter Fiscal 2021 Financial Results
Revenue Increased 3% Year-Over-Year Non-Prostate Brachytherapy Revenue Increased 104% Year-Over-Year RICHLAND, WASHINGTON – November 10, 2020 – Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding...
Isoray Announces Fourth Quarter and Full-Year Fiscal Year End 2020 Financial Results
Record Full Year Revenue and Gross Profit Full Year Revenue Increased 32% Year-Over-Year RICHLAND, WASHINGTON – September 17, 2020 – Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment...
Isoray Announces Record Third Quarter Fiscal 2020 Financial Results
Record Revenue and Gross Profit Revenue Increased 50% Year-Over-Year RICHLAND, WASHINGTON – May 12, 2020 – Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body,...
Isoray Announces Second Quarter Fiscal 2020 Financial Results
Revenue Increased 16% Year-Over-Year Gross Profit Increased 45% Year-Over-Year RICHLAND, WASHINGTON – February 11, 2020 – Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options...
Investor Resources
Research Analyst Coverage
Ascendiant Capital Markets
Edward Woo
Dawson James Securities Inc.
Jason Kolbert
Lake Street Capital Markets, LLC
Frank Takkinen
Oppenheimer & Co.
Suraj Kalia, CFA
Do you have questions?
We’ll put you in touch with someone to answer any of your investor related questions.
Investor Relations:
Mark Levin
Global IR Group
mark@globalirgroup.com
Our Management Team
Learn more about our experienced management team who are focused on growth.
Investor News Alerts
Use the button below to email us and receive the latest investor focused news from Isoray.